Table 5:
Public Healthcare Provider Perspective ICER (2018 US$) | Societal Perspective ICER (2018 US$) | |||
---|---|---|---|---|
Base case analysis | Scenario analysis* | Base case analysis | Scenario analysis* | |
Pregnant women | 2 010 | 11 015 | Dominant | 8 362 |
PLWHA | 1 749 | 11 361 | Dominant | 8 012 |
Persons with UMC | 2 618 | 11 541 | Dominant | 8 621 |
Persons aged ≥ 65 years | 2 090 | 15 888 | 2 034 | 15 801 |
Children 6–59 months | 7 490 | 23 620 | 5 267 | 21 161 |
PLWHA: Persons living with HIV/AIDS
UMC: Underlying Medical Conditions
Base case analysis: Incremental Cost-Effectiveness Ratio (ICER) estimated using the broad case definition of influenza-associated illness which includes all respiratory, all circulatory, non-respiratory/non-circulatory influenza-associated illness
Scenario analysis: ICER estimated using the narrower case definition of influenza-associated illness which includes only ILI and SARI, a subset of all respiratory influenza-associated illness
Supplementary Figure 5 presents the results of the probabilistic sensitivity analyses for the narrower case definition scenario